Health

Mandatory Compliance with Revised Prices of 137 Anti-Cancer Drugs

Raipur: The Chhattisgarh Food and Drug Administration has instructed local drug manufacturers, distributors, stockists, retail chemists, hospitals, medical colleges, and cancer treatment centres to strictly implement the revised Maximum Retail Prices (MRP) of 137 non-scheduled anti-cancer drugs. These revised prices came into effect on 9 November 2026.

The Controller of the Food and Drug Administration stated that trade margin rationalisation was implemented on these drugs through an order issued by the National Pharmaceutical Pricing Authority (NPPA) on 17 November 2026. The objective of this measure is to pass on the benefit of price reductions directly to patients. All concerned institutions must ensure that these medicines are sold according to the latest revised price list provided by the NPPA.

All establishments and medical institutions are directed to display the revised or supplementary price list prominently on their premises so that patients and their families can easily view it. Wherever applicable, this list must also be hosted on the official website of the institution.

Hospitals and medical institutions must regularly reconcile the MRP of anti-cancer drugs available on their premises and administered to patients against the revised price list. No patient can be charged an amount exceeding the applicable revised MRP. Authorities have also instructed establishments to take necessary steps to maintain adequate availability of these drugs and prevent shortages.

The Controller clarified that legal action will be initiated under the Drugs (Prices Control) Order, 2013, and other applicable statutory provisions in cases of overcharging or violation of instructions. All concerned institutions must cooperate with Food and Drug Administration officials during price verification and monitoring.

Grievance Channels for Overcharging or Drug Unavailability:

  • Chhattisgarh Price Monitoring and Resource Unit (CGPMRU): 9340597097
  • NPPA Helpline: 1800-111-255
  • Pharma Sahi Dam App/Portal
  • Email: cg-pmru@cg.gov.in
  • NPPA Email: monitoring-nppa@gov.in
  • Controller Office Email: controllerraipur@gmail.com

The Food and Drug Administration has urged patients and their families to verify revised prices while purchasing these medicines and report any irregularities through the aforementioned channels.

IMG 20250811 172353
Manish Tiwari

Show More

Related Articles

Back to top button